<?xml version="1.0" encoding="utf-8"?>
<!-- generator="tx_libfeedcreator" -->
<feed xml:lang="en" xmlns="http://www.w3.org/2005/Atom" ><title>News </title><subtitle>Helmholtz Centre for Infection Research - Press Releases </subtitle><rights>© Helmholtz Zentrum für Infektionsforschung</rights><link rel="self" type="application/atom+xml" href="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/atom.xml" hreflang="de"  /><link rel="alternate" type="text/html" href="https://www.helmholtz-hzi.de:443/en/news-events/news/" hreflang="de"  /><id>https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/atom.xml</id><updated>2020-09-05T01:23:49+02:00</updated><author><name>Verantwortlicher</name><email>info@helmholtz-hzi.de</email></author><generator>tx_libfeedcreator</generator><entry><title>Drei ERC Starting Grants gehen ans HZI</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/drei-erc-starting-grants-gehen-ans-hzi/" type="text/html" title="Drei ERC Starting Grants gehen ans HZI" hreflang="en"  /><updated>2020-09-03T11:24:00+02:00</updated><published>2020-09-03T11:24:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/drei-erc-starting-grants-gehen-ans-hzi/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/drei-erc-starting-grants-gehen-ans-hzi/" >Der Europäische Forschungsrat (ERC) zeichnet zwei Wissenschaftlerinnen und einen Wissenschaftler des Helmholtz-Zentrums für Infektionsforschung (HZI) mit einem ERC Starting Grant aus. Die Förderungen von bis zu 1,5 Millionen Euro über einen Zeitraum von fünf Jahren erhalten Jun.-Prof. Neva Caliskan vom Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Jun.-Prof. Gregor Fuhrmann vom…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/drei-erc-starting-grants-gehen-ans-hzi/" >Der Europäische Forschungsrat (ERC) zeichnet zwei Wissenschaftlerinnen und einen Wissenschaftler des Helmholtz-Zentrums für Infektionsforschung (HZI) mit einem ERC Starting Grant aus. Die Förderungen von bis zu 1,5 Millionen Euro über einen Zeitraum von fünf Jahren erhalten Jun.-Prof. Neva Caliskan vom Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Jun.-Prof. Gregor Fuhrmann vom…</content></entry><entry><title>Leap forward in the fight against antibiotic resistance</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/neuer-ansatzpunkt-im-kampf-gegen-antibiotika-resistenzen/" type="text/html" title="Leap forward in the fight against antibiotic resistance" hreflang="en"  /><updated>2020-08-18T14:00:00+02:00</updated><published>2020-08-18T14:00:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/neuer-ansatzpunkt-im-kampf-gegen-antibiotika-resistenzen/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/neuer-ansatzpunkt-im-kampf-gegen-antibiotika-resistenzen/" >Bacteria show a wide range of capabilities in withstanding antibiotic treatment or attack by our immune system, which are great challenges in infection research. Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI), have developed a novel approach to reading the activity of hundreds of genes in an…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/neuer-ansatzpunkt-im-kampf-gegen-antibiotika-resistenzen/" >Bacteria show a wide range of capabilities in withstanding antibiotic treatment or attack by our immune system, which are great challenges in infection research. Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI), have developed a novel approach to reading the activity of hundreds of genes in an…</content></entry><entry><title>Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/startschuss-fuer-europas-groesste-initiative-zur-beschleunigung-der-entwicklung-von-therapien-fuer-c/" type="text/html" title="Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats" hreflang="en"  /><updated>2020-08-18T08:19:00+02:00</updated><published>2020-08-18T08:19:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/startschuss-fuer-europas-groesste-initiative-zur-beschleunigung-der-entwicklung-von-therapien-fuer-c/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/startschuss-fuer-europas-groesste-initiative-zur-beschleunigung-der-entwicklung-von-therapien-fuer-c/" >The new consortium CARE (Corona Accelerated R&amp;D in Europe), supported by the Innovative Medicines Initiative (IMI) public-private partnership, announced its launch today to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19. With a grant totalling € 77.7 million, CARE is funded by cash contributions from the European Union…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/startschuss-fuer-europas-groesste-initiative-zur-beschleunigung-der-entwicklung-von-therapien-fuer-c/" >The new consortium CARE (Corona Accelerated R&amp;D in Europe), supported by the Innovative Medicines Initiative (IMI) public-private partnership, announced its launch today to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19. With a grant totalling € 77.7 million, CARE is funded by cash contributions from the European Union…</content></entry><entry><title>COVID-19: Immune system derails</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/covid-19-immunsystem-auf-irrwegen/" type="text/html" title="COVID-19: Immune system derails" hreflang="en"  /><updated>2020-08-06T11:00:00+02:00</updated><published>2020-08-06T11:00:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/covid-19-immunsystem-auf-irrwegen/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/covid-19-immunsystem-auf-irrwegen/" >Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. Experts from Charité – Universitätsmedizin Berlin, the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), the Helmholtz Centre for Infection Research…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/covid-19-immunsystem-auf-irrwegen/" >Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. Experts from Charité – Universitätsmedizin Berlin, the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), the Helmholtz Centre for Infection Research…</content></entry><entry><title>How many people are now immune to SARS-CoV-2?</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/wie-viele-menschen-sind-heute-schon-immun-gegen-sars-cov-20-1/" type="text/html" title="How many people are now immune to SARS-CoV-2?" hreflang="en"  /><updated>2020-08-03T10:35:00+02:00</updated><published>2020-08-03T10:35:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/wie-viele-menschen-sind-heute-schon-immun-gegen-sars-cov-20-1/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/wie-viele-menschen-sind-heute-schon-immun-gegen-sars-cov-20-1/" >Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way that will provide information on immunity or seroprevalence in the population. However, in order to compare these studies in a timely and reliable manner and provide a comprehensive evaluation, the…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/wie-viele-menschen-sind-heute-schon-immun-gegen-sars-cov-20-1/" >Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way that will provide information on immunity or seroprevalence in the population. However, in order to compare these studies in a timely and reliable manner and provide a comprehensive evaluation, the…</content></entry><entry><title>SARS-CoV-2 outbreak in German meat processing plant: Transmissions took place over long distances in air-conditioned working areas</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/sars-cov-2-ausbruch-in-deutschem-fleischzerlegebetrieb-uebertragungen-erfolgten-ueber-weite-distanze/" type="text/html" title="SARS-CoV-2 outbreak in German meat processing plant: Transmissions took place over long distances in air-conditioned working areas" hreflang="en"  /><updated>2020-07-23T11:41:00+02:00</updated><published>2020-07-23T11:41:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/sars-cov-2-ausbruch-in-deutschem-fleischzerlegebetrieb-uebertragungen-erfolgten-ueber-weite-distanze/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/sars-cov-2-ausbruch-in-deutschem-fleischzerlegebetrieb-uebertragungen-erfolgten-ueber-weite-distanze/" >In a joint study of the Helmholtz Centre for Infection Research (HZI), the University Medical Center Hamburg-Eppendorf (UKE), and the Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology (HPI), the origins of the first SARS-CoV-2 outbreak in May 2020 at Tönnies in Rheda-Wiedenbrück, Germany's largest meat processing complex, were investigated. The study results have now been…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/sars-cov-2-ausbruch-in-deutschem-fleischzerlegebetrieb-uebertragungen-erfolgten-ueber-weite-distanze/" >In a joint study of the Helmholtz Centre for Infection Research (HZI), the University Medical Center Hamburg-Eppendorf (UKE), and the Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology (HPI), the origins of the first SARS-CoV-2 outbreak in May 2020 at Tönnies in Rheda-Wiedenbrück, Germany's largest meat processing complex, were investigated. The study results have now been…</content></entry><entry><title>Exploring the RNA world of the microbiota</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/rna-welt-der-mikrobiota-erforscht/" type="text/html" title="Exploring the RNA world of the microbiota" hreflang="en"  /><updated>2020-07-16T22:23:00+02:00</updated><published>2020-07-16T22:23:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/rna-welt-der-mikrobiota-erforscht/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/rna-welt-der-mikrobiota-erforscht/" >The intestinal microbiota plays a central role for human physiology. Traditional studies have focused on the changes in microbiota composition under diverse conditions. Recently, efforts shifted towards understanding the molecular biology of intestinal bacteria. The species Bacteroides thetaiotaomicron (B. theta) has emerged as a model organism for human intestinal microbiota research. Scientists…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/rna-welt-der-mikrobiota-erforscht/" >The intestinal microbiota plays a central role for human physiology. Traditional studies have focused on the changes in microbiota composition under diverse conditions. Recently, efforts shifted towards understanding the molecular biology of intestinal bacteria. The species Bacteroides thetaiotaomicron (B. theta) has emerged as a model organism for human intestinal microbiota research. Scientists…</content></entry><entry><title>Representative, nationwide coronavirus antibody study starts in Reutlingen</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/repraesentative-bundesweite-corona-antikoerperstudie-startet-in-reutlingen/" type="text/html" title="Representative, nationwide coronavirus antibody study starts in Reutlingen" hreflang="en"  /><updated>2020-07-03T11:00:00+02:00</updated><published>2020-07-03T11:00:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/repraesentative-bundesweite-corona-antikoerperstudie-startet-in-reutlingen/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/repraesentative-bundesweite-corona-antikoerperstudie-startet-in-reutlingen/" >With the aim of obtaining a better overview of the occurrence of SARS-CoV-2 infections, a nationwide antibody study conducted by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July. Alongside four other antibody tests, a new detection method being jointly developed by the NMI Natural and Medical Sciences Institute at the University…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/repraesentative-bundesweite-corona-antikoerperstudie-startet-in-reutlingen/" >With the aim of obtaining a better overview of the occurrence of SARS-CoV-2 infections, a nationwide antibody study conducted by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July. Alongside four other antibody tests, a new detection method being jointly developed by the NMI Natural and Medical Sciences Institute at the University…</content></entry><entry><title>Mirror, mirror –  New enzyme group converts amino acid into its mirror image</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/spieglein-spieglein-neue-enzymgruppe-verwandelt-aminosaeure-in-ihr-spiegelbild/" type="text/html" title="Mirror, mirror –  New enzyme group converts amino acid into its mirror image" hreflang="en"  /><updated>2020-06-29T17:05:00+02:00</updated><published>2020-06-29T17:05:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/spieglein-spieglein-neue-enzymgruppe-verwandelt-aminosaeure-in-ihr-spiegelbild/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/spieglein-spieglein-neue-enzymgruppe-verwandelt-aminosaeure-in-ihr-spiegelbild/" >Jun Prof Jesko Köhnke heads the junior research group “Structural Biology of Biosynthetic Enzymes” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection Research (HZI). Together with his team of three, he researches the biosynthesis of natural products. His current research on an antibiotically active natural product called…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/spieglein-spieglein-neue-enzymgruppe-verwandelt-aminosaeure-in-ihr-spiegelbild/" >Jun Prof Jesko Köhnke heads the junior research group “Structural Biology of Biosynthetic Enzymes” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection Research (HZI). Together with his team of three, he researches the biosynthesis of natural products. His current research on an antibiotically active natural product called…</content></entry><entry><title>EU funds training network for young researchers</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/eu-foerdert-ausbildungsnetzwerk-fuer-junge-wissenschaftler0/" type="text/html" title="EU funds training network for young researchers" hreflang="en"  /><updated>2020-06-25T11:55:00+02:00</updated><published>2020-06-25T11:55:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/eu-foerdert-ausbildungsnetzwerk-fuer-junge-wissenschaftler0/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/eu-foerdert-ausbildungsnetzwerk-fuer-junge-wissenschaftler0/" >Prof Anna K. H. Hirsch recently received a prestigious European grant with a total funding volume of 3.2 million euros to initiate an Innovative Training Network (ITN) in the framework of the Marie Skłodowska-Curie actions. Hirsch leads the department Drug Design and Optimization at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken, a site of the Helmholtz Centre…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/eu-foerdert-ausbildungsnetzwerk-fuer-junge-wissenschaftler0/" >Prof Anna K. H. Hirsch recently received a prestigious European grant with a total funding volume of 3.2 million euros to initiate an Innovative Training Network (ITN) in the framework of the Marie Skłodowska-Curie actions. Hirsch leads the department Drug Design and Optimization at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken, a site of the Helmholtz Centre…</content></entry><entry><title>Start of HZI’s nationwide antibody study</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/start-der-bundesweiten-seropraevalenzstudie-des-hzi0/" type="text/html" title="Start of HZI’s nationwide antibody study" hreflang="en"  /><updated>2020-06-17T09:51:00+02:00</updated><published>2020-06-17T09:51:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/start-der-bundesweiten-seropraevalenzstudie-des-hzi0/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/start-der-bundesweiten-seropraevalenzstudie-des-hzi0/" >Scientific data indicate that many COVID-19 cases are not recorded due to mild or asymptomatic infections. For this reason, there is at the time no sufficient data on how many people in Germany have already been infected and thus have established a presumed immunity against SARS-CoV-2. However, these data play an important role in assessing and forecasting the further course of the pandemic.</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/start-der-bundesweiten-seropraevalenzstudie-des-hzi0/" >Scientific data indicate that many COVID-19 cases are not recorded due to mild or asymptomatic infections. For this reason, there is at the time no sufficient data on how many people in Germany have already been infected and thus have established a presumed immunity against SARS-CoV-2. However, these data play an important role in assessing and forecasting the further course of the pandemic.</content></entry><entry><title>Protection against the immune system</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/schutz-vor-dem-immunsystem/" type="text/html" title="Protection against the immune system" hreflang="en"  /><updated>2020-06-10T09:00:00+02:00</updated><published>2020-06-10T09:00:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/schutz-vor-dem-immunsystem/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/schutz-vor-dem-immunsystem/" >Virologists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig have identified a crucial survival factor in viruses. Their results were recently published in the scientific journal Proceedings of the National Academy of Sciences and could lead to a paradigm shift in virus immunology.</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/schutz-vor-dem-immunsystem/" >Virologists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig have identified a crucial survival factor in viruses. Their results were recently published in the scientific journal Proceedings of the National Academy of Sciences and could lead to a paradigm shift in virus immunology.</content></entry><entry><title>CORESMA provides evidence-based data on measures against coronavirus</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/coresma-liefert-evidenzbasierte-daten-zu-massnahmen-gegen-das-coronavirus/" type="text/html" title="CORESMA provides evidence-based data on measures against coronavirus" hreflang="en"  /><updated>2020-06-09T09:11:00+02:00</updated><published>2020-06-09T09:11:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/coresma-liefert-evidenzbasierte-daten-zu-massnahmen-gegen-das-coronavirus/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/coresma-liefert-evidenzbasierte-daten-zu-massnahmen-gegen-das-coronavirus/" >The healthcare systems of many countries are not prepared for an outbreak of the coronavirus SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI) in Braunschweig coordinates an international project to collect clinical, epidemiological and immunological data in order to provide a basis for further decisions in the corona crisis. In a highly competitive call for proposals, the CORESMA…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/coresma-liefert-evidenzbasierte-daten-zu-massnahmen-gegen-das-coronavirus/" >The healthcare systems of many countries are not prepared for an outbreak of the coronavirus SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI) in Braunschweig coordinates an international project to collect clinical, epidemiological and immunological data in order to provide a basis for further decisions in the corona crisis. In a highly competitive call for proposals, the CORESMA…</content></entry><entry><title>Small Protein, Big Impact</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/kleines-protein-grosse-wirkung00/" type="text/html" title="Small Protein, Big Impact" hreflang="en"  /><updated>2020-06-04T10:24:00+02:00</updated><published>2020-06-04T10:24:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/kleines-protein-grosse-wirkung00/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/kleines-protein-grosse-wirkung00/" >In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria. Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding protein ProQ is involved in the activation of more than 250…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/kleines-protein-grosse-wirkung00/" >In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria. Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding protein ProQ is involved in the activation of more than 250…</content></entry><entry><title>With antibody tests and new active substances against SARS-CoV-2</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/mit-antikoerpertests-und-neuen-wirkstoffen-gegen-sars-cov-20-1/" type="text/html" title="With antibody tests and new active substances against SARS-CoV-2" hreflang="en"  /><updated>2020-05-25T16:58:00+02:00</updated><published>2020-05-25T16:58:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/mit-antikoerpertests-und-neuen-wirkstoffen-gegen-sars-cov-20-1/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/mit-antikoerpertests-und-neuen-wirkstoffen-gegen-sars-cov-20-1/" >Federal Minister of Education and Research Karliczek and Lower Saxony’s Minister for Science and Culture Thümler were guests at the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The scientists at the HZI provided them with an overview of the current state of research on COVID-19, in particular a new nationwide epidemiological antibody study.</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/mit-antikoerpertests-und-neuen-wirkstoffen-gegen-sars-cov-20-1/" >Federal Minister of Education and Research Karliczek and Lower Saxony’s Minister for Science and Culture Thümler were guests at the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The scientists at the HZI provided them with an overview of the current state of research on COVID-19, in particular a new nationwide epidemiological antibody study.</content></entry><entry><title>Interaction Between Immune System and Brain</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/interaktion-von-immunsystem-und-gehirn/" type="text/html" title="Interaction Between Immune System and Brain" hreflang="en"  /><updated>2020-05-20T09:10:00+02:00</updated><published>2020-05-20T09:10:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/interaktion-von-immunsystem-und-gehirn/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/interaktion-von-immunsystem-und-gehirn/" >Interferons are important messenger molecules in the immune system, assisting in the fight against pathogens such as influenza viruses and probably also SARS-CoV-2. However, interferon might also be involved in immune-brain interactions unrelated to an infection and may have an influence on learning ability. This is indicated by a study with mice from the Technische Universität Braunschweig,…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/interaktion-von-immunsystem-und-gehirn/" >Interferons are important messenger molecules in the immune system, assisting in the fight against pathogens such as influenza viruses and probably also SARS-CoV-2. However, interferon might also be involved in immune-brain interactions unrelated to an infection and may have an influence on learning ability. This is indicated by a study with mice from the Technische Universität Braunschweig,…</content></entry><entry><title>ifo Institute and Helmholtz Infection Researchers Favour Limited, Gradual Opening in Germany</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/ifo-und-helmholtz-infektionsforscher-fuer-begrenzte-schrittweise-oeffnungen/" type="text/html" title="ifo Institute and Helmholtz Infection Researchers Favour Limited, Gradual Opening in Germany" hreflang="en"  /><updated>2020-05-13T10:51:00+02:00</updated><published>2020-05-13T10:51:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/ifo-und-helmholtz-infektionsforscher-fuer-begrenzte-schrittweise-oeffnungen/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/ifo-und-helmholtz-infektionsforscher-fuer-begrenzte-schrittweise-oeffnungen/" >The ifo Institute and the Helmholtz Centre for Infection Research (HZI) have called for a “prudent, step-by-step opening process” in the coronavirus crisis. They recommend that the policy should be to do more testing to limit the increase in infections as the lockdown is progressively eased. “These measures are essential to limit the health and economic costs of the pandemic,” says a joint study…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/ifo-und-helmholtz-infektionsforscher-fuer-begrenzte-schrittweise-oeffnungen/" >The ifo Institute and the Helmholtz Centre for Infection Research (HZI) have called for a “prudent, step-by-step opening process” in the coronavirus crisis. They recommend that the policy should be to do more testing to limit the increase in infections as the lockdown is progressively eased. “These measures are essential to limit the health and economic costs of the pandemic,” says a joint study…</content></entry><entry><title>Prime Minister of Lower Saxony Stephan Weil and Minister Björn Thümler visit the Helmholtz Centre for Infection Research</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/niedersaechsischer-ministerpraesident-stephan-weil-und-minister-bjoern-thuemler-besuchen-das-helmhol/" type="text/html" title="Prime Minister of Lower Saxony Stephan Weil and Minister Björn Thümler visit the Helmholtz Centre for Infection Research" hreflang="en"  /><updated>2020-05-08T16:58:00+02:00</updated><published>2020-05-08T16:58:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/niedersaechsischer-ministerpraesident-stephan-weil-und-minister-bjoern-thuemler-besuchen-das-helmhol/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/niedersaechsischer-ministerpraesident-stephan-weil-und-minister-bjoern-thuemler-besuchen-das-helmhol/" >A distinguished visitor to the Helmholtz Centre for Infection Research: The Prime Minister of Lower Saxony Stephan Weil and Lower Saxony’s Minister of Science and Culture Björn Thümler visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The focus of the visit was on current challenges and innovative solutions, especially in the fight against SARS-CoV-2 and the future…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/niedersaechsischer-ministerpraesident-stephan-weil-und-minister-bjoern-thuemler-besuchen-das-helmhol/" >A distinguished visitor to the Helmholtz Centre for Infection Research: The Prime Minister of Lower Saxony Stephan Weil and Lower Saxony’s Minister of Science and Culture Björn Thümler visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The focus of the visit was on current challenges and innovative solutions, especially in the fight against SARS-CoV-2 and the future…</content></entry><entry><title>Adding flexibility to CRISPR targets in the genome</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/adding-flexibility-to-crispr-targets-in-the-genome/" type="text/html" title="Adding flexibility to CRISPR targets in the genome" hreflang="en"  /><updated>2020-05-07T10:47:00+02:00</updated><published>2020-05-07T10:47:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/adding-flexibility-to-crispr-targets-in-the-genome/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/adding-flexibility-to-crispr-targets-in-the-genome/" >CRISPR technologies are revolutionary genome-editing tools that rely on molecular scissors called Cas nucleases to cut DNA. While these scissors can be programmed to cut virtually any sequence, that target must be flanked by a special sequence called a PAM (Protospacer Adjacent Motif). The PAM sequence is up to six nucleotides in length and can vary widely between Cas nucleases. To allow all…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/adding-flexibility-to-crispr-targets-in-the-genome/" >CRISPR technologies are revolutionary genome-editing tools that rely on molecular scissors called Cas nucleases to cut DNA. While these scissors can be programmed to cut virtually any sequence, that target must be flanked by a special sequence called a PAM (Protospacer Adjacent Motif). The PAM sequence is up to six nucleotides in length and can vary widely between Cas nucleases. To allow all…</content></entry><entry><title>Hope for antibody therapy against Covid-19</title><link rel="alternate" href="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/hoffnung-auf-antikoerpertherapie-gegen-covid-19/" type="text/html" title="Hope for antibody therapy against Covid-19" hreflang="en"  /><updated>2020-05-07T08:41:00+02:00</updated><published>2020-05-07T08:41:00+02:00</published><id>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/hoffnung-auf-antikoerpertherapie-gegen-covid-19/</id><summary type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/hoffnung-auf-antikoerpertherapie-gegen-covid-19/" >Neutralizing antibodies are the interceptors of our immune system. They bind precisely to pathogens and prevent them from entering our cells. After an infection, the immune system needs about two weeks to produce mature antibodies. In severe cases of Covid-19, the body's immune reaction often comes too late for the patient. One option for acute treatment would therefore be to administer…</summary><content type="text" xml:base="https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/hoffnung-auf-antikoerpertherapie-gegen-covid-19/" >Neutralizing antibodies are the interceptors of our immune system. They bind precisely to pathogens and prevent them from entering our cells. After an infection, the immune system needs about two weeks to produce mature antibodies. In severe cases of Covid-19, the body's immune reaction often comes too late for the patient. One option for acute treatment would therefore be to administer…</content></entry></feed>